Weather changes may not affect pain, studies say | Researchers study non-responses to local anesthesia | Researchers ID protein linked to pain control
January 11, 2017
News for the pain professional
Pain Research News
Weather changes may not affect pain, studies say
Data from two Australian studies suggested changes in the weather do not affect patients' lower back or knee arthritis pain. Dr. Robert Shmerling of Beth Israel Deaconess Medical Center said previous studies have yielded inconsistent data and that, despite this evidence, it is impossible to prove that a weather event cannot affect pain. (1/10) 
LinkedIn Twitter Facebook Google+ Email
Researchers study non-responses to local anesthesia
Study data is lacking on why some patients are resistant to local anesthesia. Researchers are looking at whether the condition may be linked to genetics and are trying to raise awareness of the problem among physicians and patients.
BBC (1/9) 
LinkedIn Twitter Facebook Google+ Email
Other News
Become a future leader of Healthcare Technology
With the online MSHI from The University of Scranton, you will make data-driven healthcare decisions that keep patient-centered care at the forefront of the constantly evolving medical field. The program focuses on developing an integrative approach to patient care and will equip you with interdisciplinary tools in the healthcare informatics field. Download the brochure
Treatment News
Botox helps reduce use, overuse of other migraine therapies
Research in The Journal of Headache and Pain found using onabotulinumtoxinA as a preventive therapy for chronic migraine allowed some patients to discontinue oral preventives or overusing acute medications. The study found chronic migraines were reduced to episodic migraines for about two-thirds of patients.
MedPage Today (free registration) (1/3) 
LinkedIn Twitter Facebook Google+ Email
FDA OKs Egalet's opioid painkiller, allows some claims of abuse deterrence
Egalet's opioid painkiller Arymo ER, a long-acting variation of morphine, has been approved by the FDA to treat severe pain that requires daily, around-the-clock, long-term opioid treatment. The agency also allowed the drug's claim that it deters abuse by those who seek to dissolve and inject it but did not allow the claim that it deters abuse by those who seek to chew or snort it.
Reuters (1/9) 
LinkedIn Twitter Facebook Google+ Email
Other News
Policy & Trends
CMS officials call for culture change to reduce opioid abuse
Personalized patient-centered care and an examination of prescribing practices must be part of efforts to reduce opioid abuse, CMS officials wrote in a blog post. They wrote that reducing the opioid abuse epidemic will require a coordinated culture change in health care, patient outreach, collaboration with states and payers, new policies and the use of more patient-centered strategies.
Health IT Analytics (1/6) 
LinkedIn Twitter Facebook Google+ Email
Expert: Breakthrough pain may not have role in chronic pain
The definition of breakthrough pain has been narrowed to pain that occurs despite use of opioid medications that adequately control pain most of the time, but debate remains on whether breakthrough pain needs more treatment or is "in fact just pain," writes Jane Ballantyne of the University of Washington School of Medicine's Department of Anesthesiology and Pain Medicine. Higher doses of opioids lead to adverse effects with long-term use but not better pain relief, Ballantyne writes, suggesting the concept of breakthrough pain may not have a role in chronic pain.
Medscape (free registration)/Pain (1/5) 
LinkedIn Twitter Facebook Google+ Email
APS News
Register for the 2017 Annual Scientific Meeting!
The 2017 Annual Scientific Meeting brings together science and innovation. Share your ideas and connect with your pain peers in Pittsburgh! The APS Annual Scientific Meeting will be held May 17-20 at the David L. Lawrence Convention Center. Register early and save. Learn more.
LinkedIn Twitter Facebook Google+ Email
Everyone can rise above their circumstances and achieve success if they are dedicated to and passionate about what they do.
Nelson Mandela,
activist and political leader
LinkedIn Twitter Facebook Google+ Email
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information